US Stock Insider Trading | Vicarious Surgical disclosed two insider trading transactions on February 24

K-LinePoet · 2026-03-05T21:22:42+00:00

On February 24, 2026, Vicarious Surgical disclosed insider trading, with Director Sachs Adam David selling 942 shares on February 20 at a price of $2.09 per share. Additionally, Khalifa Sammy also conducted stock sales. The company is committed to developing innovative surgical robot technology with the goal of improving surgical efficiency and reducing healthcare costs.

K-LinePoet

2026-03-05 21:22:42

Abstract generation in progress

On February 24, 2026, Vicarious Surgical (RBOT) disclosed two insider transactions. Director Sachs Adam David sold 942 shares on February 20, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 24, 2026	Director	Sachs Adam David	February 20, 2026	Sell	942	2.09	1,966.71
February 24, 2026	Director	Khalifa Sammy	February 20, 2026	Sell	754	2.08	1,571.41
December 4, 2025	>10% Shareholder	Sachs Adam David	December 3, 2025	Sell	463	2.95	1,366.78
December 4, 2025	>10% Shareholder	Khalifa Sammy	December 3, 2025	Sell	239	2.97	709.83
November 21, 2025	>10% Shareholder	Khalifa Sammy	November 20, 2025	Sell	653	2.74	1,791.83
November 21, 2025	>10% Shareholder	Sachs Adam David	November 20, 2025	Sell	816	2.72	2,215.44
September 4, 2025	>10% Shareholder	Khalifa Sammy	September 3, 2025	Sell	239	5.72	1,366.96
September 4, 2025	>10% Shareholder	Sachs Adam David	September 3, 2025	Sell	463	5.76	2,665.21
August 27, 2025	Director	Tang Donald F	August 26, 2025	Sell	2,753	6.70	$18,400
August 21, 2025	>10% Shareholder	Sachs Adam David	August 20, 2025	Sell	817	6.03	4,927.49

[Company Information]

Vicarious Surgical Inc. is a company registered in Delaware and incorporated on May 6, 2020. It is a next-generation robotics company developing disruptive technology aimed at improving surgical efficiency, enhancing patient outcomes, and reducing healthcare costs. The company’s novel surgical approach combines proprietary humanoid surgical robots and virtual reality to enable surgeons to perform minimally invasive surgeries inside patients. The company’s technology has received FDA Breakthrough Device designation, and Vicarious Surgical believes Vicarious System is the first surgical robot to receive this designation. The company is led by experienced technology experts, medical device professionals, and a team of physicians, headquartered in Waltham, Massachusetts.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.